Insulin Resistance, Diabetes
10
2
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Treatment Research
16 treatments under study, led by Insulin
Research Leaders
12 sponsors active, led by Maastricht University
Related Conditions
Often studied with 12 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
85.7%
-0.9% vs benchmark
10%
1 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (10)
Diabetes, Insulin, Gut, Enteric Supplementation Trial
Studying Phenotypes of Gestational Diabetes Mellitus in an Asian Pregnant Cohort
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise
Diabetes, Insulin Resistance and Body Composition
Topical Insulin for Postoperative Wound Healing
Duality of Lipids: the Athlete's Paradox
Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia
Validation of a Novel Screening Test for Maternal Insulin Resistance
Acute Effect of HP-211 (Axulin) on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans
Regulation of Endogenous Glucose Production by Brain Insulin Action
Research Network
Common Treatments
- Insulin2
- 2g Tablets1
- Acute Bout Of Endurance Exercise1
- Diabetesinsulin Resistancecontrol1
- Povidoneiodine1
Active Sponsors
- Maastricht University1
- Northwestern University1
- German Diabetes Center1
- Housey Healthcare ULC1
- National University Health System, Singapore1
Top Investigators
University of New Brunswick
Glycemic Index Laboratories, Inc
Shandong First Medical University
Northwestern University
Cairo University
Related Conditions
- Birth Weight1
- Lipid Metabolism Disorders1
- Gut Microbiome1
- Blood Glucose1
- Intergenerational Relations1